NCT06528288

Brief Summary

The purpose of this study is to determine if the method for injecting local anesthesia affects patients' pain and opioid usage after surgery. The investigators will compare subcutaneous anesthesia, injections of anesthesia under the skin, to a method called erector spinae plane block (ESPB). An ESPB injection involves placing local anesthesia along the muscles and bones in the back, using a special type of x-ray called fluoroscopy for guidance. The Investigators will use patient reported outcomes (PROs) and track subjects' opioid usage to find out if there is a difference between ESPB and subcutaneous anesthesia. The investigators hypothesize that patients who get ESPB injections will use less opioids and report less pain after lumbar fusion surgery compared to patients who receive subcutaneous anesthesia injections.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Sep 2024Jul 2027

First Submitted

Initial submission to the registry

July 25, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 30, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 13, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

2.3 years

First QC Date

July 25, 2024

Last Update Submit

March 12, 2026

Conditions

Keywords

Erector Spinae Plane BlockSpinal FusionPatient Reported OutcomesOpioid Usage

Outcome Measures

Primary Outcomes (3)

  • MOS 36 Item Short Form Health Status Survey (SF-36)

    Questionnaire related to a patient's general health, bodily pain, physical function, and mental health. Scoring includes eight scaled scores, which are the weighted sums of the questions in their section. Scales are converted into a 0-100 scale. The lower the score the more disability. The higher the score the more functionality and therefore indicating better outcome.

    3 months

  • Oswestry Disability Index

    Questionnaire related to a patient's back pain and its impact on their day-to-day activities. There are 10 questions, each weighted from 0-5 points. The point total of each question is added together to give a final scaled score ranging from 0-50. Lower scores near 0 are indicative of better outcome and less disability, while higher scores near 50 indicate worse outcomes and more disability.

    3 months

  • Postoperative Opioid Usage

    This is a tracking sheet for the amount of opioid medications used in the first 2 weeks of postoperative recovery.

    2 weeks

Study Arms (2)

Erector Spinae Plane Block

EXPERIMENTAL

An erector spinae plane block (ESPB) will be administered prior to the surgical procedure, but after the patient receives general anesthesia. The injection will consist of 10 mL of saline, 20 mL of liposomal bupivacaine, and 30 mL of bupivacaine. This will be injected along the erector spinae fascial plane at the surgical levels. Fluoroscopy will be used for guidance during the injection.

Procedure: Erector Spinae Plane Block

Subcutaneous Anesthesia

ACTIVE COMPARATOR

A subcutaneous anesthesia injection will be administered after the surgery has been completed, but while the patient is under general anesthesia. The injection will consist of 10 mL of saline, 20 mL of liposomal bupivacaine, and 30 mL of bupivacaine. This will be injected around the surgical incision, subcutaneously.

Procedure: Subcutaneous Anesthesia

Interventions

The erector spinae plane block (ESPB) is a method for injecting local anesthesia to reduce pain related to a surgical procedure. The anesthesia is theorized to spread along the paraspinal fascia and anesthetize a larger area, resulting in patients reporting less pain and using less opioids postoperatively.

Erector Spinae Plane Block

Subcutaneous anesthesia injection involves placement of local anesthesia under the skin around the surgical incision. This is thought to reduce pain from the incision site postoperatively.

Subcutaneous Anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The individual has signed and dated a study specific informed consent form approved by the Institutional Review Board at UMMHC.
  • The individual is at least 18 years of age.
  • The individual is skeletally mature (over the age of 18).
  • The patient is scheduled for a one or two level lumbar spinal fusion.

You may not qualify if:

  • Patients unable to consent for themselves.
  • Pregnant women.
  • Non-English speaking subjects.
  • Prisoners.
  • Spinal fusion procedures for a diagnosis of fracture, tumor, and/or infection.
  • Patients who have used greater than 150 morphine milligram equivalents of opioids in the month prior to their operation.
  • Patients with a body mass index (BMI) of 40 or greater.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMass Chan Medical School/UMass Memorial Medical Center

Worcester, Massachusetts, 01655, United States

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Michael Stauff, MD

    UMass Chan Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael P Stauff, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will be masked to the treatment arm. The research team (outcomes assessors) involved in evaluation of subjects will be blinded to the treatment arm.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 25, 2024

First Posted

July 30, 2024

Study Start

September 13, 2024

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial will be shared after deidentification.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data will be available immediately following publication and will remain available for six (6) years.
Access Criteria
The data will be provided to researchers who provide a methodologically sound proposal.

Locations